Hancock Whitney Corp Trims Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hancock Whitney Corp trimmed its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 53,065 shares of the medical equipment provider’s stock after selling 258 shares during the period. Intuitive Surgical comprises 0.8% of Hancock Whitney Corp’s portfolio, making the stock its 22nd biggest holding. Hancock Whitney Corp’s holdings in Intuitive Surgical were worth $26,069,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in ISRG. Hazlett Burt & Watson Inc. boosted its holdings in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. boosted its stake in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the period. Ullmann Wealth Partners Group LLC grew its holdings in shares of Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares during the last quarter. Meeder Advisory Services Inc. increased its stake in Intuitive Surgical by 0.3% in the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after buying an additional 22 shares during the period. Finally, One Wealth Management Investment & Advisory Services LLC lifted its holdings in Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after buying an additional 23 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at approximately $12,391,166.97. This trade represents a 42.84 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Jamie Samath sold 269 shares of the company’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the completion of the sale, the insider now owns 8,757 shares in the company, valued at $4,727,816.73. The trade was a 2.98 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,539 shares of company stock valued at $26,112,364. 0.80% of the stock is owned by insiders.

Analyst Ratings Changes

ISRG has been the topic of a number of research analyst reports. Mizuho upped their target price on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. BTIG Research set a $535.00 price target on Intuitive Surgical in a research note on Friday, October 18th. Finally, Robert W. Baird boosted their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $524.61.

Intuitive Surgical Stock Up 0.8 %

Shares of Intuitive Surgical stock opened at $552.00 on Monday. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The firm has a market capitalization of $196.61 billion, a P/E ratio of 88.08, a PEG ratio of 5.39 and a beta of 1.39. The company has a 50 day moving average price of $504.73 and a 200 day moving average price of $464.13.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.